Key result
Droxidopa versus midodrine systematic review protocol evaluates standing blood pressure in neurogenic orthostatic hypotension.
Why the study?
Does droxidopa improve standing blood pressure and orthostatic intolerance symptoms compared to midodrine in adults with neurogenic orthostatic hypotension?
Does droxidopa improve standing blood pressure and orthostatic intolerance symptoms compared to midodrine in adults with neurogenic orthostatic hypotension?
This is a protocol for a systematic review comparing droxidopa and midodrine for neurogenic orthostatic hypotension.
Answers are grounded in this paper and cite their sources.
Direct comparison lacking; leaves open optimal first-line agent for standing BP and symptoms in neurogenic orthostatic hypotension.
REVIEW QUESTION: The question of this review is: what is the effectiveness of droxidopa compared to midodrine on standing blood pressure and orthostatic intolerance symptoms in adults with neurogenic orthostatic hypotension?
No takes yet. Share an insight, caveat, or question.
Patrick et al. (2017) studied this question. Droxidopa compared to midodrine is the focus of a systematic review protocol evaluating effectiveness on standing blood pressure and symptoms in neurogenic orthostatic hypotension.
Synapse has enriched 10 related papers. Consider them for comparative context: